255 related articles for article (PubMed ID: 22943816)
21. Vogt-Koyanagi-Harada syndrome.
Moorthy RS; Inomata H; Rao NA
Surv Ophthalmol; 1995; 39(4):265-92. PubMed ID: 7725227
[TBL] [Abstract][Full Text] [Related]
22. The outcomes of indocyanine green angiography monitored immunotherapy in Vogt-Koyanagi-Harada disease.
Chee SP; Jap A
Br J Ophthalmol; 2013 Feb; 97(2):130-3. PubMed ID: 23212203
[TBL] [Abstract][Full Text] [Related]
23. Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
Andrade RE; Muccioli C; Farah ME; Nussenblatt RB; Belfort R
Am J Ophthalmol; 2004 Mar; 137(3):572-4. PubMed ID: 15013890
[TBL] [Abstract][Full Text] [Related]
24. Management of ocular complications of Vogt-Koyanagi-Harada syndrome.
Perente I; Utine CA; Cakir H; Kaya V; Tutkun IT; Yilmaz OF
Int Ophthalmol; 2009 Feb; 29(1):33-7. PubMed ID: 17952373
[TBL] [Abstract][Full Text] [Related]
25. Vogt-Koyanagi-Harada disease in the developing world.
Concha del Río LE; Arellanes-García L
Int Ophthalmol Clin; 2010; 50(2):189-99. PubMed ID: 20375871
[No Abstract] [Full Text] [Related]
26. [Vogt Koyanagi Harada syndrome in children: diagnosis and management].
Benfdil N; Baha Ali T; Jellab B; Moutaouakil A
Bull Soc Belge Ophtalmol; 2010; (314):15-8. PubMed ID: 20480746
[TBL] [Abstract][Full Text] [Related]
27. [Vogt-Koyanagi-Harada syndrome in children].
Laghmari M; Karim A; Ibrahimy W; Essakalli NH; Mohcine Z
J Fr Ophtalmol; 2002 Jun; 25(6):636-40. PubMed ID: 12223954
[TBL] [Abstract][Full Text] [Related]
28. Treatment of Vogt-Koyanagi-Harada disease by corticosteroids and immunosuppressive agents.
Rao NA
Ocul Immunol Inflamm; 2006 Apr; 14(2):71-2. PubMed ID: 16597535
[No Abstract] [Full Text] [Related]
29. Vogt-Koyanagi-Harada syndrome in children: report of a case and review of the literature.
Berker N; Ozdamar Y; Soykan E; Ozdal P; Ozkan SS
Ocul Immunol Inflamm; 2007; 15(4):351-7. PubMed ID: 17763135
[TBL] [Abstract][Full Text] [Related]
30. Vogt-Koyanagi-Harada disease presenting as optic neuritis.
Rajendram R; Evans M; Khurana RN; Tsai JH; Rao NA
Int Ophthalmol; 2007; 27(2-3):217-20. PubMed ID: 17437062
[TBL] [Abstract][Full Text] [Related]
31. Management of a rare presentation of Vogt-Koyanagi-Harada disease in human immunodeficiency virus/acquired immunodeficiency disease syndrome patient.
Priya D; Sudharshan S; Biswas J
Indian J Ophthalmol; 2017 May; 65(5):413-416. PubMed ID: 28574002
[TBL] [Abstract][Full Text] [Related]
32. [Diagnosis of Vogt-Koyanagi-Harada-syndrome (uveoencephalitis) (author's transl)].
Sundmacher R
Klin Monbl Augenheilkd; 1975 Apr; 166(4):540-6. PubMed ID: 1206928
[TBL] [Abstract][Full Text] [Related]
33. [Vogt-Koyanagi-Harada syndrome: importance of rapid diagnosis and therapeutic intervention].
Bouchenaki N; Morisod L; Herbort CP
Klin Monbl Augenheilkd; 2000 May; 216(5):290-4. PubMed ID: 10863695
[TBL] [Abstract][Full Text] [Related]
34. Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes.
Lavezzo MM; Sakata VM; Morita C; Rodriguez EE; Abdallah SF; da Silva FT; Hirata CE; Yamamoto JH
Orphanet J Rare Dis; 2016 Mar; 11():29. PubMed ID: 27008848
[TBL] [Abstract][Full Text] [Related]
35. Earlier immunomodulatory treatment is associated with better visual outcomes in a subset of patients with Vogt-Koyanagi-Harada disease.
Urzua CA; Velasquez V; Sabat P; Berger O; Ramirez S; Goecke A; Vásquez DH; Gatica H; Guerrero J
Acta Ophthalmol; 2015 Sep; 93(6):e475-80. PubMed ID: 25565265
[TBL] [Abstract][Full Text] [Related]
36. Vogt-Koyanagi-Harada disease: Novel insights into pathophysiology, diagnosis and treatment.
Du L; Kijlstra A; Yang P
Prog Retin Eye Res; 2016 May; 52():84-111. PubMed ID: 26875727
[TBL] [Abstract][Full Text] [Related]
37. Vogt-Koyanagi-Harada disease: clinical and demographic characteristics of patients in a specialized eye hospital in Turkey.
Ozdal P; Ozdamar Y; Yazici A; Teke MY; Ozturk F
Ocul Immunol Inflamm; 2014 Aug; 22(4):277-86. PubMed ID: 24328424
[TBL] [Abstract][Full Text] [Related]
38. [Sensorineural hearing loss evolution in Vogt-Koyanagi-Harada syndrome].
Rodríguez Rivera V; Garrigues HP; Gallego Pinazo R
Acta Otorrinolaringol Esp; 2011; 62(6):465-8. PubMed ID: 21167466
[TBL] [Abstract][Full Text] [Related]
39. Vogt-Koyanagi-Harada disease: diagnosis and treatments update.
Bordaberry MF
Curr Opin Ophthalmol; 2010 Nov; 21(6):430-5. PubMed ID: 20829689
[TBL] [Abstract][Full Text] [Related]
40. Vogt-Koyanagi-Harada syndrome in two patients with immunoglobulin A nephropathy.
Matsuo T; Masuda I; Ota K; Yamadori I; Sunami R; Nose S
Acta Med Okayama; 2007 Oct; 61(5):305-9. PubMed ID: 17971847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
